Incorporating Network Pharmacology and Experimental Validation to Identify Bioactive Compounds and Potential Mechanisms of Digitalis in Treating Anaplastic Thyroid Cancer

被引:2
作者
Zhu, Lei [1 ,2 ,3 ,4 ]
Liang, Ruimin [3 ,4 ,5 ]
Guo, Yawen [3 ,4 ,5 ]
Cai, Yefeng [3 ,4 ,6 ]
Song, Fahuan [3 ,4 ,5 ]
Hu, Yiqun [3 ,4 ,5 ]
Liu, Yunye [3 ,4 ,5 ]
Ge, Minghua [1 ,3 ,4 ,5 ]
Zheng, Guowan [3 ,4 ,5 ]
机构
[1] Soochow Univ, Suzhou Med Coll, Suzhou 215123, Jiangsu, Peoples R China
[2] Wenzhou Med Univ, Hosp 5, Lishui Cent Hosp, Dept Head & Neck Surg, Lishui 323020, Zhejiang, Peoples R China
[3] Key Lab Endocrine Gland Dis Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China
[4] Clin Res Ctr Canc Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China
[5] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Otolaryngol & Head & Neck Ctr,Canc Ctr,Dept Head &, Hangzhou 310014, Zhejiang, Peoples R China
[6] Wenzhou Med Univ, Affiliated Hosp 1, Dept Thyroid Surg, Wenzhou 325000, Zhejiang, Peoples R China
来源
ACS OMEGA | 2024年 / 9卷 / 13期
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
TARGETED THERAPY; APOPTOSIS; CELLS; IDENTIFICATION; MIGRATION; PROLIFERATION; DATABASE; DOCKING; GENES;
D O I
10.1021/acsomega.4c00373
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Anaplastic thyroid cancer (ATC) is one of the most lethal malignant tumors for which there is no effective treatment. There are an increasing number of studies on herbal medicine for treating malignant tumors, and the classic botanical medicine Digitalis and its active ingredients for treating heart failure and arrhythmias have been revealed to have significant antitumor efficacy against a wide range of malignant tumors. However, the main components of Digitalis and the molecular mechanisms of its anti-ATC effects have not been extensively studied. Here, we screened the main components and core targets of Digitalis and verified the relationship between the active components and targets through network pharmacology, molecular docking, and experimental validation. These experiments showed that the active ingredients of Digitalis inhibit ATC cell activity and lead to ATC cell death through the apoptotic pathway.
引用
收藏
页码:15590 / 15602
页数:13
相关论文
共 50 条
  • [41] RETRACTED: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer (Retracted Article)
    Li, Zhaoyi
    Liu, Qingling
    Zhu, Ying
    Wu, Lichao
    Liu, Wenhong
    Li, Junfeng
    Zhang, Zhiqian
    Tao, Fangfang
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [42] Uncovering the Effects and Molecular Mechanisms of Shaoyao Decoction Against Colorectal Cancer Using Network Pharmacology Analysis Coupled With Experimental Validation and Gut Microbiota Analysis
    Rong, Yaojun
    Zhang, Guiyu
    Ye, Wenhao
    Qi, Linhua
    Hao, Xiaojiang
    Li, Xiaolin
    Zhang, Wuhong
    Chao, Yangfa
    Gu, Shaodong
    [J]. CANCER MEDICINE, 2025, 14 (06):
  • [43] Discovering Potential Anti-Oral Squamous Cell Carcinoma Mechanisms from Kochiae Fructus Using Network-Based Pharmacology Analysis and Experimental Validation
    Kim, Youn-Sook
    Lee, Jin-Choon
    Lee, Minhyung
    Oh, Hae-Jin
    An, Won G. G.
    Sung, Eui-Suk
    [J]. LIFE-BASEL, 2023, 13 (06):
  • [44] Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study
    Siddiqui, Arif Jamal
    Elkahoui, Salem
    Alshammari, Ahmed Mohajja
    Patel, Mitesh
    Ghoniem, Ahmed Eisa Mahmoud
    Abdalla, Randa Abdeen Husien
    Dwivedi-Agnihotri, Hemlata
    Badraoui, Riadh
    Adnan, Mohd
    [J]. PHARMACEUTICALS, 2025, 18 (03)
  • [45] Integrating UPLC-Q-Exactive Orbitrap/MS, Network pharmacology and experimental validation to reveal the potential mechanism of Kadsura coccinea roots in Colon Cancer
    Liu, Shi-qi
    Shen, Bing-bing
    Li, Hui-ying
    Yao, Yu-xuan
    Li, Bin
    Yu, Huang-he
    Tian, Xing
    Zhou, Xu-dong
    Sheng, Wen-bing
    Mouthe, Guy Paulin Kemayou
    Wang, Wei
    Yang, Yu-pei
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2025, 337
  • [46] Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation
    Li, Ruijie
    Ke, Haoliang
    Liu, Pan
    Yang, Qian
    Li, Yuxin
    Ke, Longzhu
    Wang, Xiuping
    Wu, Chaoyan
    Zhang, Yingwen
    [J]. HELIYON, 2024, 10 (17)
  • [47] Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis
    Bi, Yiming
    Han, Xin
    Lai, Yigui
    Fu, Yingchang
    Li, Kongzheng
    Zhang, Wei
    Wang, Qiang
    Jiang, Xuefeng
    Zhou, Yingchun
    Liang, Hongfeng
    Fan, Huijie
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2021, 278
  • [48] Uncovering the effects and molecular mechanism of Astragalus membranaceus (Fisch.) Bunge and its bioactive ingredients formononetin and calycosin against colon cancer: An integrated approach based on network pharmacology analysis coupled with experimental validation and molecular docking
    Hu, Yu
    Zhai, Wenjuan
    Tan, Duanling
    Chen, Haipeng
    Zhang, Guiyu
    Tan, Xuanjing
    Zheng, Yuting
    Gao, Wenhui
    Wei, Yijie
    Wu, Jinjun
    Yang, Xin
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] Network Pharmacology Combined with Molecular Docking, Molecular Dynamics, and In Vitro Experimental Validation Reveals the Therapeutic Potential of Thymus vulgaris L. Essential Oil (Thyme Oil) against Human Breast Cancer
    Alotaibi, Nahaa M.
    Alotaibi, Modhi O.
    Alshammari, Nawaf
    Adnan, Mohd
    Patel, Mitesh
    [J]. ACS OMEGA, 2023, 8 (50): : 48344 - 48359
  • [50] Network pharmacology and molecular docking identify mechanisms of medicinal plant-derived 1,2,3,4,6-penta-O-galloyl-beta-D-glucose treating gastric cancer
    Ren, Man
    Yang, Yuan
    Li, Dan
    Zhao, Nannan
    Wang, Yuping
    Zhou, Yongning
    [J]. BIOCELL, 2023, 47 (05) : 977 - 989